Category Innovation/ R&D

Single European Patent Dominates IP Summit As European Parliament Vote Nears

Brussels, Belgium - As the value of intellectual property reaches unprecedented heights, policymakers, business leaders, and legal experts discussed the need for international patent harmonisation during a two-day patent conference in Brussels last week. With the vote on the European unitary patent and common litigation system just days away from parliamentary vote, participants focussed on what the new system may mean to business.

WHO Members Agree On “Strategic Work Plan” On Health R&D – But No Convention

After three days and two nights of tough negotiations to address the global gap in research and development for neglected diseases at the World Health Organization, member states agreed to endorse a strategic work plan that includes proposals on the coordination, financing, and monitoring of R&D expenditures separately, but not to advance the idea of an overarching framework. The recommendation for a global R&D convention proved divisive to the very end of the negotiations.

WHO Negotiations To Address Medical R&D Global Gaps Head Deep Into Night

Negotiations on the follow-up of the report of the expert group on research and development for neglected diseases tonight were continuing in a late-night session at the World Health Organization. At press time, member states were discussing options to address the research coordination, financing, and monitoring of medical R&D expenditures for the health needs of developing countries.

International Instrument On Medical R&D Still On Negotiating Table At WHO

World Health Organization member states gathering this week at the WHO headquarters in a meeting to address global gaps in the drug development system said that there is still much work to be done before consensus can be reached on a resolution. For now, the latest draft resolution keeps a wide range of monitoring, coordinating, and financing options on the table, not yet setting a clear direction.

Event This Week: The Creation Of Unitary Patent Protection In The European Union

The Creation of Unitary Patent Protection in the European Union
Paris, 29-30 November 2012
Maison de la Recherche
54, rue de Varenne
75007 Paris
Find here (http://bit.ly/Vbb2CB) more information about the conference.

After more than 30 years of negotiations, 25 of 27 Member States reached a conclusion on the future Unitary Patent System. The central aim of the two draft Regulations on the creation of unitary patent protection and on the applicable translation arrangements is to reduce the costs of patent protection and translation fees in the EU. The European Council on 28-29 June 2012 agreed to split the seat of the EU Patent Court between Paris, London and Munich. The Council’s suggestion to delete Articles 6-8 of the draft Regulation on the creation of the unitary patent provoked strong criticism in the European Parliament which postponed the vote on the proposal scheduled for 4 July 2012. A conference organised by the Academy of European Law (ERA) in cooperation with Queen Mary University of London in Paris on 29-30 November 2012 will offer a platform for discussion on the latest proposals which are now being discussed within the European Parliament.

UNITAID: Alternative Funding Mechanism For AIDS Drugs Saving Lives

UNITAID, an alternative funding mechanism for pharmaceuticals to the poor, said today that its work has helped develop new ways to treat children infected with HIV where there was previously little commercial incentive. The statement alongside the World AIDS Day announcement that the number of newly infected children continues to decline. UNITAID called for the international community to help children already living with the disease.